Balance Sheet Illumina, Inc.

Equities

ILMN

US4523271090

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 16:00:00 2024-09-17 EDT			5-day change	1st Jan Change
130.21 ^USD	+0.53%		+4.90%	-6.49%

09-13	RBC Raises Price Target on Illumina to $252 From $242, Keeps Outperform Rating	MT
09-06	European Commission Withdraws Previous Decisions on Illumina-Grail Merger After Court Ruling	MT

6.ILWqLPficaaDj-OXD5IYAW_4jZV_ogWRqUMHOWyG6jU.R_HnFbKAN_C22IzEVcRtMy25z94g0jf42xZODwazqHxC0NBrlqs_zev-gA

Published financial data: ILLUMINA, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	3.54B	3.24B	4.53B	4.58B	4.5B
Total Revenues	3.54B	3.24B	4.53B	4.58B	4.5B
Cost of Goods Sold, Total	1.04B	1.01B	1.3B	1.44B	1.56B
Gross Profit	2.5B	2.23B	3.22B	3.14B	2.94B
Selling General & Admin Expenses, Total	864M	949M	1.57B	1.57B	1.64B
R&D Expenses	575M	609M	935M	1.22B	1.21B
Amortization of Goodwill and Intangible Assets - (IS)	34M	28M	71M	173M	191M
Other Operating Expenses, Total	1.47B	1.59B	2.57B	2.97B	3.04B
Operating Income	1.03B	645M	652M	179M	-94M
Interest Expense, Total	-52M	-49M	-61M	-26M	-77M
Interest And Investment Income	75M	41M	-	11M	58M
Net Interest Expenses	23M	-8M	-61M	-15M	-19M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	4M	32M	9M	-13M	1M
EBT, Excl. Unusual Items	1.06B	669M	600M	151M	-112M
Restructuring Charges	-	-	-	-30M	-152M
Merger & Related Restructuring Charges	-43M	-117M	-745M	-	-
Impairment of Goodwill	-	-	-	-3.91B	-712M
Gain (Loss) On Sale Of Investments	53M	270M	917M	-122M	-40M
Gain (Loss) On Sale Of Assets	54M	-	-	-	-
Asset Writedown	-	-	-	-	-
In Process R&D Expenses	-	-	-	-	-115M
Legal Settlements	-	27M	-	-619M	-20M
Other Unusual Items	-1M	7M	112M	198M	34M
EBT, Incl. Unusual Items	1.12B	856M	884M	-4.34B	-1.12B
Income Tax Expense	128M	200M	122M	68M	44M
Earnings From Continuing Operations	990M	656M	762M	-4.4B	-1.16B
Net Income to Company	990M	656M	762M	-4.4B	-1.16B
Minority Interest	12M	-	-	-	-
Net Income - (IS)	1B	656M	762M	-4.4B	-1.16B
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	1B	656M	762M	-4.4B	-1.16B
Net Income to Common Excl. Extra Items	1B	656M	762M	-4.4B	-1.16B
Per Share Items
Net EPS - Basic	6.82	4.46	5.08	-28.05	-7.35
Basic EPS - Continuing Operations	6.82	4.46	5.08	-28.05	-7.35
Basic Weighted Average Shares Outstanding	147M	147M	150M	157M	158M
Net EPS - Diluted	6.74	4.45	5.04	-28.05	-7.35
Diluted EPS - Continuing Operations	6.74	4.45	5.04	-28.05	-7.35
Diluted Weighted Average Shares Outstanding	149M	148M	151M	157M	158M
Normalized Basic EPS	4.57	2.84	2.5	0.6	-0.44
Normalized Diluted EPS	4.51	2.83	2.48	0.6	-0.44
Supplemental Items
EBITDA	1.22B	832M	903M	573M	338M
EBITA	1.06B	676M	727M	358M	103M
EBIT	1.03B	645M	652M	179M	-94M
EBITDAR	1.29B	905M	986M	665M	461M
Total Revenues (As Reported)	3.54B	3.24B	4.53B	4.58B	4.5B
Effective Tax Rate - (Ratio)	11.45	23.36	13.8	-1.57	-3.94
Current Domestic Taxes	39M	38M	91M	16M	1M
Current Foreign Taxes	84M	45M	107M	75M	77M
Total Current Taxes	123M	83M	198M	91M	78M
Deferred Domestic Taxes	0	124M	-73M	-7M	-39M
Deferred Foreign Taxes	5M	-7M	-3M	-16M	5M
Total Deferred Taxes	5M	117M	-76M	-23M	-34M
Normalized Net Income	671M	418M	375M	94.38M	-70M
Interest on Long-Term Debt	52M	49M	61M	26M	77M
Supplemental Operating Expense Items
Advertising Expense	28M	28M	48M	53M	36M
Research And Development Expense From Footnotes	647M	682M	1.18B	1.32B	1.35B
Net Rental Expense, Total	72M	73M	83M	92M	123M
Imputed Operating Lease Interest Expense	15.45M	15.11M	18.22M	6.28M	26.05M
Imputed Operating Lease Depreciation	56.55M	57.89M	64.78M	85.72M	96.95M
Stock-Based Comp., COGS (Total)	23M	25M	27M	32M	36M
Stock-Based Comp., R&D Exp. (Total)	66M	74M	276M	153M	155M
Stock-Based Comp., SG&A Exp. (Total)	105M	95M	638M	181M	189M
Total Stock-Based Compensation	194M	194M	941M	366M	380M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	2.04B	1.81B	1.23B	2.01B	1.05B
Short Term Investments	1.37B	1.66B	107M	26M	6M
Total Cash And Short Term Investments	3.41B	3.47B	1.34B	2.04B	1.05B
Accounts Receivable, Total	573M	487M	664M	688M	752M
Other Receivables	-	-	-	-	-
Total Receivables	573M	487M	664M	688M	752M
Inventory	359M	372M	431M	568M	587M
Prepaid Expenses	105M	152M	279M	268M	216M
Deferred Tax Assets Current	-	-	-	-	-
Total Current Assets	4.45B	4.48B	2.71B	3.56B	2.61B
Gross Property Plant And Equipment	2.01B	2.13B	2.49B	2.71B	2.69B
Accumulated Depreciation	-568M	-678M	-796M	-962M	-1.14B
Net Property Plant And Equipment	1.44B	1.45B	1.7B	1.74B	1.55B
Long-term Investments	273M	418M	213M	211M	196M
Goodwill	824M	897M	7.11B	3.24B	2.54B
Other Intangibles, Total	145M	142M	2.54B	2.58B	2.4B
Deferred Tax Assets Long-Term	64M	20M	-	-	-
Deferred Charges Long-Term	-	-	705M	705M	590M
Other Long-Term Assets, Total	115M	171M	232M	212M	217M
Total Assets	7.32B	7.58B	15.22B	12.25B	10.11B
Liabilities
Accounts Payable, Total	149M	192M	332M	293M	245M
Accrued Expenses, Total	204M	223M	335M	287M	348M
Current Portion of Long-Term Debt	-	511M	-	1.25B	-
Current Portion of Leases	45M	51M	71M	76M	86M
Current Income Taxes Payable	86M	68M	98M	97M	79M
Unearned Revenue Current, Total	167M	186M	234M	245M	252M
Other Current Liabilities	14M	13M	23M	527M	560M
Total Current Liabilities	665M	1.24B	1.09B	2.77B	1.57B
Long-Term Debt	1.14B	673M	1.7B	1.49B	1.49B
Long-Term Leases	695M	671M	774M	744M	687M
Unearned Revenue Non Current	42M	44M	63M	63M	77M
Other Non Current Liabilities	160M	259M	852M	586M	543M
Total Liabilities	2.7B	2.89B	4.48B	5.65B	4.37B
Common Stock, Total	2M	2M	2M	2M	2M
Additional Paid In Capital	3.56B	3.82B	8.94B	9.21B	9.56B
Retained Earnings	4.07B	4.72B	5.48B	1.14B	-19M
Treasury Stock	-3.02B	-3.85B	-3.7B	-3.76B	-3.79B
Comprehensive Income and Other	5M	2M	17M	3M	-1M
Total Common Equity	4.61B	4.69B	10.74B	6.6B	5.74B
Minority Interest	-	-	-	-	-
Total Equity	4.61B	4.69B	10.74B	6.6B	5.74B
Total Liabilities And Equity	7.32B	7.58B	15.22B	12.25B	10.11B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	147M	146M	157M	158M	159M
ECS Total Common Shares Outstanding	147M	146M	157M	158M	159M
Book Value / Share	31.38	32.15	68.41	41.77	36.13
Tangible Book Value	3.64B	3.66B	1.08B	780M	797M
Tangible Book Value Per Share	24.79	25.03	6.89	4.94	5.01
Total Debt	1.88B	1.91B	2.54B	3.56B	2.26B
Net Debt	-1.53B	-1.57B	1.2B	1.52B	1.21B
Debt Equivalent of Unfunded Proj. Benefit Obligation	46M	51M	56M	51M	59M
Debt Equivalent Oper. Leases	576M	584M	664M	736M	984M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Equity Method Investments, Total	53M	104M	173M	183M	168M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	108M	106M	92M	247M	276M
Inventories - Work In Process, Total	225M	244M	312M	386M	402M
Inventories - Finished Goods, Total	26M	22M	27M	28M	30M
Buildings, Total	44M	44M	44M	44M	44M
Machinery, Total	718M	812M	939M	1.12B	1.2B
Full Time Employees	7.7K	7.8K	9.8K	11.5K	10.59K
Part Time Employees	-	50	50	60	50
Accumulated Allowance for Doubtful Accounts (Supple)	2M	4M	3M	4M	7M
Order Backlog	980M	816M	1.04B	1.03B	653M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	1B	656M	762M	-4.4B	-1.16B
Depreciation & Amortization - CF	151M	156M	176M	215M	235M
Amortization of Goodwill and Intangible Assets - (CF)	37M	31M	75M	179M	197M
Depreciation & Amortization, Total	188M	187M	251M	394M	432M
Amortization of Deferred Charges, Total - (CF)	46M	40M	32M	-	-
(Gain) Loss From Sale Of Asset	-54M	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-53M	-270M	-917M	122M	40M
Asset Writedown & Restructuring Costs	-	-	-	3.91B	927M
Stock-Based Compensation (CF)	194M	194M	754M	366M	380M
Tax Benefit from Stock Options	-	-	-	-	-
Other Operating Activities, Total	-78M	200M	-185M	-204M	-50M
Change In Accounts Receivable	-58M	89M	-164M	-12M	-40M
Change In Inventories	25M	-12M	-58M	-135M	-20M
Change In Accounts Payable	-35M	40M	60M	-38M	-44M
Change in Other Net Operating Assets	-126M	-44M	10M	389M	14M
Cash from Operations	1.05B	1.08B	545M	392M	478M
Capital Expenditure	-209M	-189M	-208M	-286M	-195M
Cash Acquisitions	-	-98M	-2.44B	-85M	-29M
Divestitures	-14M	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-180M	-1M
Investment in Marketable and Equity Securities, Total	986M	-135M	1.53B	-40M	-6M
Other Investing Activities, Total	-18M	-132M	52M	-	-
Cash from Investing	745M	-554M	-1.07B	-591M	-231M
Long-Term Debt Issued, Total	-	-	988M	991M	-
Total Debt Issued	-	-	988M	991M	-
Long-Term Debt Repaid, Total	-550M	-	-517M	-	-1.24B
Total Debt Repaid	-550M	-	-517M	-	-1.24B
Issuance of Common Stock	59M	61M	60M	63M	67M
Repurchase of Common Stock	-406M	-827M	-511M	-54M	-40M
Other Financing Activities, Total	-	-	-71M	-	-2M
Cash from Financing	-897M	-766M	-51M	1B	-1.21B
Foreign Exchange Rate Adjustments	-1M	8M	-3M	-22M	-
Net Change in Cash	898M	-232M	-578M	779M	-963M
Supplemental Items
Cash Interest Paid	-	-	-	-	73M
Cash Income Tax Paid (Refund)	164M	119M	233M	122M	65M
Levered Free Cash Flow	693M	692M	1.36B	667M	513M
Unlevered Free Cash Flow	680M	683M	1.37B	683M	561M
Change In Net Working Capital	136M	-88M	23M	-277M	-4M
Net Debt Issued / Repaid	-550M	-	471M	991M	-1.24B

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	9	5.41	3.57	0.81	-0.53
Return on Total Capital	10.37	6.16	4.1	0.95	-0.65
Return On Equity %	23.24	14.1	9.87	-50.8	-18.81
Return on Common Equity	23.94	14.1	9.87	-50.8	-18.81
Margin Analysis
Gross Profit Margin %	70.59	68.88	71.25	68.61	65.3
SG&A Margin	24.39	29.3	34.62	34.25	36.35
EBITDA Margin %	34.32	25.69	19.95	12.5	7.5
EBITA Margin %	30.06	20.87	16.06	7.81	2.29
EBIT Margin %	29.01	19.91	14.41	3.9	-2.09
Income From Continuing Operations Margin %	27.94	20.25	16.84	-96.07	-25.78
Net Income Margin %	28.28	20.25	16.84	-96.07	-25.78
Net Avail. For Common Margin %	28.28	20.25	16.84	-96.07	-25.78
Normalized Net Income Margin	18.95	12.91	8.29	2.06	-1.55
Levered Free Cash Flow Margin	19.56	21.38	30.1	14.54	11.39
Unlevered Free Cash Flow Margin	19.18	21.09